Results 1 to 10 of about 23,000 (252)

Immunogenicity, immune persistence, and safety of japanese encephalitis vaccine schedules among adults in Ningxia, China [PDF]

npj Vaccines
Live attenuated and vero-cell-inactivated Japanese Encephalitis vaccines (LJEV, IJEV) have been in common use in young children in China since 1989 and 2004, associated with large reductions in Japanese encephalitis (JE) incidence.
Dan Wu, Qikai Yin, Ying Zhang, Yixing Li, Liwei Zhou, Shihong Fu, Xue Li, Hui Zheng, Yiqun Wu, Luping Zhou, Qian Zhang, Mingshuang Li, Tingting Yan, Xueying Qin, Lance Rodewald, Junhui Wu, Yanru Sun, Zhijie An, Zundong Yin, Huanyu Wang, Yonghua Hu   +20 more
doaj   +3 more sources

Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial [PDF]

Human Vaccines & Immunotherapeutics, 2021
Co-administration of vaccines could be an efficient strategy to increase vaccination uptake and reduce the number of clinic visits. This randomized controlled study aimed to evaluate the immunogenicity and safety of enterovirus 71 (EV71) vaccine co ...
Xiaoyu Liu, Wanqi Yang, Chao Zhang, Heng Wu, Ruize Wang, Qiang Ding, Yan Hu, Yongli Xiong, Shaobai Zhang, Lin Wang   +9 more
doaj   +4 more sources

Japanese Encephalitis Vaccines [PDF]

Current Treatment Options in Infectious Diseases, 2020
As an eminently vaccine-preventable disease, encephalitis caused by Japanese encephalitis virus (JEV) has attracted an unusually high degree of attention from those seeking to develop viral vaccines. Since the 1950s, all types of JEV vaccines including inactivated, recombinant and live attenuated ones have been licensed.
Vijaya Satchidanandam
openalex   +3 more sources

Japanese Encephalitis Vaccine Acceptance and Strategies for Travelers: Insights from a Scoping Review and Practitioners in Endemic Countries [PDF]

Vaccines, 2023
Japanese encephalitis (JE) remains the cause of vaccine-preventable encephalitis in individuals living in endemic areas and international travelers. Although rare, the disease’s high fatality rate emphasizes the need for effective immunization.
Punyisa Asawapaithulsert, Thundon Ngamprasertchai, Amornphat Kitro   +2 more
doaj   +2 more sources

Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children [PDF]

Human Vaccines & Immunotherapeutics, 2022
Japanese encephalitis is the main cause of viral encephalitis in Asia. In a previous single-arm vaccine trial, an inactivated chromatographically purified Japanese encephalitis Vero cell vaccine (CVI-JE; JEVACTM) was safe and immunogenic in 152 Thai ...
Weerawan Hattasingh, Pornthep Chanthavanich, Chukiat Sirivichayakul, Watcharee Arunsodsai, Surachai Surangsrirat, Termsang Srisuwannaporn, Benjawan Kaewma, Sutee Yoksan, Kriengsak Limkittikul, Junwei Yang, Yu Mao   +10 more
doaj   +2 more sources

Safety of Japanese encephalitis vaccines [PDF]

Human Vaccines & Immunotherapeutics, 2021
Japanese encephalitis (JE) is an endemic disease dominantly in the Asia-Pacific region with mortality rate varying between 3% and 30%. Long-term neuropsychiatric sequelae developed in 30-50% of the survivors. There is no available antiviral therapy for JE. JE vaccines play a major role in preventing this devastating disease.
Yali Hu, Ping‐Ing Lee
openalex   +4 more sources

Safety and dose-sparing effect of Japanese encephalitis vaccine administered by microneedle patch in uninfected, healthy adults (MNA-J): a randomised, partly blinded, active-controlled, phase 1 trial

The Lancet Microbe, 2022
Summary: Background: It is unclear whether microneedle vaccinations of Japanese encephalitis virus can induce sufficient neutralising antibodies and reduce the amount of vaccine needed.
Hiroaki Iwata, PhD, Kosuke Kakita, PhD, Keisuke Imafuku, MD, Shota Takashima, PhD, Naoya Haga, MD, Yasuyuki Yamaguchi, MD, Kenji Taguchi, MS, Takayoshi Oyamada, MS   +7 more
doaj   +2 more sources

Japanese Encephalitis Vaccine Generates Cross-Reactive Memory T Cell Responses to Zika Virus in Humans [PDF]

Journal of Tropical Medicine, 2022
Objective. Zika virus (ZIKV) and Japanese encephalitis virus (JEV) are mosquito-borne flaviviruses with sequence homology. ZIKV circulates in some regions where JEV also circulates, or where JE vaccination is used.
Ran Wang, Meng Zhang, Linlin Zhang, Mengjia Liu, Chao Shan, Jing An, Zhengde Xie   +6 more
doaj   +2 more sources

The changing epidemiology of Japanese encephalitis and New data: the implications for New recommendations for Japanese encephalitis vaccine [PDF]

Tropical Diseases, Travel Medicine and Vaccines, 2017
The epidemiology of Japanese Encephalitis and risk to the traveler has changed and continues to evolve. The spread of Japanese Encephalitis virus into new environments, changes in agricultural practice and animal vectors, climate change, peri-urban ...
Bradley Connor, William B. Bunn
doaj   +2 more sources

Vaccines for preventing Japanese encephalitis [PDF]

Cochrane Database of Systematic Reviews, 2007
Vaccination is recognized as the only practical measure for preventing Japanese encephalitis. Production shortage, costs, and issues of licensure impair vaccination programmes in many affected countries. Concerns over vaccine effectiveness and safety also have a negative impact on acceptance and uptake.To evaluate vaccines for preventing Japanese ...
Karin L. Schiøler, Miny Samuel, Khin Lay Wai   +2 more
openalex   +5 more sources